Global Life Sciences
Overview
Featured News & Insights
0015
Contacts
Services
Advising on the full scope of regulatory, compliance and enforcement, litigation and transactional matters, we can offer you a holistic legal approach that will smooth your path as you navigate industry changes, technological advances, market demands and policy hurdles.
Regions
From high-profile transactions to regulatory issues and complex litigation, we collaborate across borders and disciplines to help our clients in more than 70 countries face challenges and embrace opportunities.

All Professionals
sort


Capabilities
- Antitrust and Competition
- Capital Markets
- Commercial Litigation and Disputes
- Emerging Companies and Venture Capital
- Environmental, Health, and Safety
- Food, Drug and Medical Device
- Global Arbitration, Trade and Advocacy
- Government Strategies
- Healthcare
- IP Litigation
- M&A
- Privacy and Cybersecurity
- Private Equity
- Product Liability and Mass Torts
- Technology
- Technology and Life Sciences Transactions
Related Resources
Related Blogs
News & Insights
Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026EU Biotech Act I: Parliament and Council back Europe’s biotech competitiveness agenda – SPC incentive now the key battlegroundSeptember 21, 2026Partners Michael Resch and Smitha Stansbury Join Sidley to Expand Global Life Sciences PracticesSeptember 21, 2026Sidley Secures US$640 Million Settlement for Genesis Healthcare Special Restructuring Committee Following High-Stakes Bankruptcy LitigationSeptember 18, 2026
Conferences
GoodLifeSci
Press Releases
Announcements
FDA and SEC Announce Coordination on Scrutiny of Public DisclosuresSeptember 16, 2026Illinois Expands Attorney General Review of Healthcare TransactionsAugust 13, 2026Shifting Expectations: FDA Takes a First Step Toward Making GRAS Notifications MandatoryAugust 12, 2026The Evolving Global Landscape for Orphan Drug ExclusivityJuly 28, 2026
Food, Drug and Medical Device Update
Healthcare Update
Food, Drug and Medical Device Update
Global Life Sciences Update
New York Ethics Opinion Warns Lawyers on Qui Tam DeceptionSeptember 2, 2026Recent ESG Developments in EuropeAugust 2026Through the Looking Glass: What WHA79 Reveals About the Future of Global Life SciencesAugust 2026Switzerland Expands Integrity Rules to Medical Devices: Key Compliance Implications for Medtech CompaniesAugust 2026
Law360
Sidley Life Sciences Briefing
Sidley Life Sciences Briefing
Sidley Life Sciences Briefing
A New World Order – Market Access, MFN, and GeopoliticsTuesday, November 10, 2026Sidley & Trinity Capital Life Sciences ReceptionThursday, October 22, 2026Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Swiss MedTech 2026Tuesday, August 25, 2026
Events
Receptions
Conferences
Conferences
Partners Michael Resch and Smitha Stansbury Join Sidley to Expand Global Life Sciences PracticesSeptember 21, 2026Sidley Secures US$640 Million Settlement for Genesis Healthcare Special Restructuring Committee Following High-Stakes Bankruptcy LitigationSeptember 18, 2026Sidley Represents GSK in Connection With Its €3.5 Billion Issuance of NotesSeptember 17, 2026Sidley Represents American Healthcare REIT in US$819 Million Common Stock OfferingSeptember 14, 2026
Press Releases
Announcements
Announcements
Announcements
Sidley Wins Seven Honors at the 2026 LMG Life Sciences Americas AwardsSeptember 11, 2026Managing IP Recognizes Sidley and 12 Lawyers in IP Stars 2026July 31, 2026Sidley Shortlisted in 16 Categories at the LMG Life Sciences Americas Awards 2026July 20, 2026Sidley Highly Ranked in Chambers USA 2026June 4, 2026
Accolades
Accolades
Accolades
Accolades
EU Biotech Act I: Parliament and Council back Europe’s biotech competitiveness agenda – SPC incentive now the key battlegroundSeptember 21, 2026HHS Secretary Announces Intent to Extend HHS-OIG Exclusion Authority to CMS, Expanding the Administration’s Anti-Fraud CampaignSeptember 16, 2026When AI Changes The Deal: Seven AI-related Considerations for Life Sciences M&A DealmakersSeptember 8, 2026Is my product a medical device? EU Court judgment clarifies that the test includes objective function and intended purpose, and provides guidance relevant to software and AI-enabled toolsAugust 31, 2026
GoodLifeSci
GoodLifeSci
GoodLifeSci
GoodLifeSci
Renewed Market Optimism @ JPM 2026January 12, 2026What's Ahead for Life Sciences Dealmaking @ JPM 2026January 12, 2026Top 10 FDA Areas We Are Watching @ JPM 2026January 12, 2026Regulatory Considerations for the Next Wave of Development-Stage Transactions @ JPM 2026January 12, 2026
Videos
Videos
Videos
Videos




































